A research study to determine how well a combination of the medicine semaglutide and once weekly investigational drug works for people with type 2 diabetes
Fill in your details and Sign Up today
About the Study
This study is to look at how well Semaglutide (Ozempic) works when taken together with different doses of a new once weekly investigational medicine called NNC0480-0389. Semaglutide is a medicine that doctors can already prescribe for the treatment of type 2 diabetes.
The purpose is to investigate how safe, and how well tolerated, the two medicines are when used alone or in combination at different doses in working to lower blood sugar levels in people with type 2 diabetes.
Study participants may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.
To take part in the study, participants should be:
- Type 2 Diabetes
- Not able to control blood sugars with Metformin, or with diet and exercise alone
- BMI range: 25 to 40
- A1C range: 7%-10%
- Age range: 18 to 75 years